Kewaunee Scientific Corporation
KEQU · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.60 | -0.35 | 0.02 | -0.62 |
| FCF Yield | 0.00% | 3.18% | 9.84% | -1.60% |
| EV / EBITDA | 30.35 | 24.00 | 12.70 | 58.11 |
| Quality | ||||
| ROIC | 2.09% | 2.64% | 3.97% | 1.63% |
| Gross Margin | 28.13% | 29.44% | 31.16% | 27.36% |
| Cash Conversion Ratio | -1.68 | 1.83 | 1.90 | -1.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.90% | 6.28% | 3.09% | 0.74% |
| Free Cash Flow Growth | 0.00% | -43.54% | 400.88% | -138.11% |
| Safety | ||||
| Net Debt / EBITDA | 1.24 | -0.18 | 3.56 | 11.66 |
| Interest Coverage | -1.29 | 4.55 | 7.31 | 1.98 |
| Efficiency | ||||
| Inventory Turnover | 1.42 | 1.44 | 1.62 | 1.55 |
| Cash Conversion Cycle | 22.94 | 87.44 | 82.63 | 89.91 |